Financiële vergelijkingen Revolution Medicines, Inc.
Aandelen
RVMD
US76155X1000
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
40,67 USD | -1,57% |
|
-3,60% | -7,02% |
13/01 | Revolution Medicines, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 10:30 AM | |
08/01 | REVOLUTION MEDICINES, INC. : Een koopadvies van UBS | ZM |
Toevoegen aan een lijst 0 geselecteerde | Omzet (Y-1) | Nettomarge (Y-1) | Ebit-marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | |
---|---|---|---|---|---|---|---|
11,58 mln. | 3.768,28% | 4.207,12% | 34,76% | 30,38% | 3.85x | ||
7,98 mld. | 9,74% | 13,98% | 6,52% | 3,82% | 0.46x | ||
15,4 mld. | 8,91% | 20,12% | 22,55% | 5,12% | 3.33x | ||
1,68 mld. | 24,61% | 29,93% | 5,07% | 4,31% | 1.46x | ||
2,33 mld. | 42,31% | 50,91% | 18,27% | 14,91% | -1.85x | ||
8,12 mld. | 7,54% | 19,31% | 6,9% | 3,58% | 2x | ||
532 mln. | 40,26% | - | - | - | - | ||
6,85 mld. | 68,84% | 61,9% | 28,59% | 21,29% | 2.38x | ||
1,16 mld. | 14,5% | 31,94% | 14,11% | 6,29% | 0.4x | ||
2,11 mld. | 19,17% | 21,38% | 45,7% | 19,42% | -0.58x | ||
1,97 mld. | 17,37% | 26,9% | 4,69% | 2,75% | 0.69x | ||
4,13 mld. | 11,49% | 20,31% | 16,7% | 6,95% | 2.34x | ||
1,04 mld. | 27,44% | 35,35% | 9,95% | 7,09% | -1.51x | ||
1,63 mld. | 13,88% | 14,92% | 13,86% | 6,82% | 1.36x | ||
509 mln. | 13,19% | 41,67% | 17,29% | 8,69% | 0.19x | ||
1,56 mld. | 23,57% | 27% | 30,95% | 18,86% | -0.61x | ||
343 mln. | 1,04% | 10,29% | 34,35% | 12,03% | -1.95x | ||
788 mln. | 46,45% | 44,8% | 76,34% | 13,26% | 3.21x | ||
686 mln. | 19,38% | 22,41% | 9% | - | -1.79x | ||
Gemiddelde | 3,1 mld. | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 0,74x | |
Gewogen gemiddelde per kap. | 5,29 mld. | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 1,05x |
- Beurs
- Aandelen
- Koers RVMD
- Sector Revolution Medicines, Inc.
- Financiële vergelijkingen